Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Tumor Progression02:07

Tumor Progression

6.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

3.4K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlates of Sexually Transmitted Infection (STI) Positivity and Implementation of Point-of-Care STI Testing at a Mobile Clinic for Women Who Inject Drugs in Seattle, WA.

Sexually transmitted diseases·2026
Same author

Practice facilitation to implement stepped care for unhealthy alcohol use in HIV clinics: study protocol for a type III hybrid effectiveness-implementation study.

Addiction science & clinical practice·2026
Same author

"You're Hoping for the Best, but Preparing for the Worst": Discussions of Starting Buprenorphine in the Context of Fentanyl Use with Clinicians and People Who Use Fentanyl.

Journal of general internal medicine·2026
Same author

Recognition of depression by nurses in primary healthcare in Zimbabwe: Cross-sectional study.

Global mental health (Cambridge, England)·2026
Same author

Addressing substance use and mental illness among Quinault Indian Nation adolescents and young adults: community perspectives on community and cultural connection.

Addiction science & clinical practice·2026
Same author

Differences in buprenorphine initiation and retention for opioid use disorder between primary care and substance use disorder specialty care settings.

Journal of substance use and addiction treatment·2026

Related Experiment Video

Updated: May 8, 2025

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

8.8K

Prostate luminal cell plasticity and cancer.

Emily C Williams1, Maho Shibata1

  • 1Department of Anatomy and Cell Biology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA; The George Washington University Cancer Center, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Cancer Letters
|December 27, 2024
PubMed
Summary

Cellular plasticity in prostate cancer drives treatment resistance. Understanding how epigenetic changes and the tumor microenvironment influence this plasticity is key for developing new therapies.

Keywords:
PlasticityProstate cancerProstate developmentTransdifferentiation

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.2K
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.0K

Related Experiment Videos

Last Updated: May 8, 2025

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

8.8K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

45.2K
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.0K

Area of Science:

  • Oncology
  • Cell Biology
  • Genetics

Background:

  • Cellular plasticity is a key mechanism enabling prostate cancer to develop treatment resistance.
  • Studies have explored cellular differentiation and plasticity in normal prostate tissue and during regeneration.
  • Recent research investigates plasticity and clonal dynamics in prostate cancer progression using advanced models.

Purpose of the Study:

  • To review findings on cellular plasticity in prostate cancer.
  • To highlight the role of the tumor microenvironment and epigenetic regulators.
  • To discuss implications for disease treatment and tumor immunogenicity.

Main Methods:

  • Review of independent studies utilizing mouse models.
  • Analysis of single-cell RNA sequencing data.
  • Examination of genetic lineage tracing approaches.
  • Investigation using immune-competent genetically-engineered mouse models.

Main Results:

  • Cellular plasticity is crucial for prostate cancer progression and treatment resistance.
  • The tumor microenvironment significantly influences cellular plasticity.
  • Epigenetic regulators play a critical role in promoting cellular plasticity.
  • Changes in epigenetic alterations affecting cell plasticity impact tumor immunogenicity.

Conclusions:

  • Cellular plasticity is a fundamental aspect of prostate cancer's therapeutic resistance.
  • Epigenetic modifications and tumor microenvironment interactions are central to plasticity.
  • Further research into the link between plasticity, epigenetics, and immunogenicity is vital for advancing prostate cancer treatment strategies.